双阴性T细胞通过TNFα-JAK1-ICAM-1细胞毒性轴杀伤急性髓系白血病
该研究采用基于流式细胞术的高通量筛选,比较双阴性T细胞(DNT)与敏感或耐药急性髓系白血病(AML)细胞相互作用时的表面分子表达谱,鉴定出TNFα依赖的细胞毒性通路。DNT分泌的TNFα经非经典JAK1依赖途径上调AML细胞ICAM-1,通过ICAM-1与淋巴细胞功能相关抗原1结合增强杀伤,包括对DNT耐药的白血病细胞。
要点
- DNT与敏感AML细胞作用时分泌TNFα,使AML细胞对DNT杀伤敏感,包括原本耐药的细胞。
- TNFα通过非经典JAK1依赖途径上调AML细胞ICAM-1。
- DNT经ICAM-1与淋巴细胞功能相关抗原1更有效结合AML细胞,增强杀伤。
核心结论
- 研究揭示DNT杀伤AML的TNFα-JAK1-ICAM-1轴,以提高治疗疗效。
研究设计与样本
- 采用基于流式细胞术的高通量筛选,比较DNT与DNT敏感或耐药AML细胞相互作用时的表面分子表达谱。
主要发现
- DNT与敏感AML靶细胞相遇时分泌的TNFα使AML细胞对DNT介导的杀伤敏感,包括原本对DNT耐药的细胞。
- TNFα通过非经典JAK1依赖途径上调AML细胞ICAM-1。
- DNT通过ICAM-1与淋巴细胞功能相关抗原1更有效地与AML细胞结合,导致杀伤增强。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic double-negative T cells (DNTs) are a rare T-cell subset that effectively target acute myeloid leukemia (AML) without inducing graft-versus-host disease in an allogeneic setting. A phase 1 clinical trial demonstrated the feasibility, safety, and potential efficacy of allogeneic DNT therapy among patients with relapsed AML. However, the molecular mechanisms of DNT-mediated cytotoxicity against AML remain elusive. Thus, we used a flow cytometry-based high throughput screening to compare the surface molecule expression profile on DNTs during their interaction with DNT-susceptible or -resistant AML cells and identified a tumor necrosis factor α (TNFα)-dependent cytotoxic pathway in DNT-AML interaction. TNFα secreted by DNTs, upon encountering susceptible AML targets, sensitized AML cells to DNT-mediated killing, including those otherwise resistant to DNTs. Mechanistically, TNFα upregulated ICAM-1 on AML cells through a noncanonical JAK1-dependent pathway. DNTs then engaged with AML cells more effectively through an ICAM-1 receptor, lymphocyte function-associated antigen 1, leading to enhanced killing. These results reveal a TNFα-JAK1-ICAM-1 axis in DNT-mediated cytotoxicity against AML to improve therapeutic efficacy.
引用
- Tin E, Lee JB, Khatri I, et al. Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood Adv. 2024. PMID: 38547431. doi:10.1182/bloodadvances.2023011739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。